World Bank   Report issue

Foundation Phase 1 Phase 3
Founded: Washington D.C. United States (1944)

Organization Overview

First Clinical Trial
2000
NCT00344669
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

World Bank

Active Ingredients

Drugs in Phase 3 Trials (5)

coartem (1 trial)

dihydroqinghaosu (1 trial)

lumefantrine (Coartem) (1 trial)

piperaquinoline (1 trial)

zn2+ (1 trial)

Drugs in Phase 1 Trials (2)

calcium (1 trial)

calcium carbonate (1 trial)

Drugs in Other Trials (2)

albendazole (Albenza) (1 trial)

methadone (methadose) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholera (Phase 3)

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 9